Markets:

Overview

News

Currencies

International

Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

84.63 +0.71 (+0.85%)

Streaming Delayed Price Updated: 9:44 AM EDT, Apr 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

3 Profitable Stocks We Think Twice About

April 09, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

3 Cash-Producing Stocks Walking a Fine Line

April 08, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Ignore

April 07, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

3 Russell 2000 Stocks We’re Skeptical Of

March 25, 2026

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...

Via StockStory

Lantheus Holdings Inc (NASDAQ:LNTH) Beats Q4 Estimates but 2026 Guidance Disappoints ↗

February 26, 2026

Via Chartmill

Lantheus Holdings Inc. (NASDAQ:LNTH) Presents a Compelling Value Investment Case ↗

February 20, 2026

Via Chartmill

Lantheus Holdings Inc (NASDAQ:LNTH) Presents a Compelling Value Case with Strong Fundamentals ↗

January 06, 2026

Via Chartmill

Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application ↗

March 17, 2026

The agency is now slated to decide on the company’s application seeking approval for the diagnostic kit by June 29.

Via Stocktwits

Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

March 17, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

3 Reasons to Sell LNTH and 1 Stock to Buy Instead

March 12, 2026

What a fantastic six months it’s been for Lantheus. Shares of the company have skyrocketed 57%, hitting $83.14. This run-up might have investors contemplatin...

Via StockStory

Topics Supply Chain

Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

March 10, 2026

Let’s dig into the relative performance of Lantheus (NASDAQ:LNTH) and its peers as we unravel the now-completed Q4 medical devices & supplies - imaging, diag...

Via StockStory

Topics Artificial Intelligence

Why Lantheus Holdings Stock Popped by Almost 12% Last Month ↗

March 09, 2026

Investors were clearly impressed by the medical device specialist's fourth-quarter performance.

Via The Motley Fool

Why Is LNTH Stock Up After Hours? ↗

March 06, 2026

Lantheus said that the FDA approved its PYLARIFY TruVu injection.

Via Stocktwits

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

March 06, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

March 02, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®

March 02, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus (LNTH) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Lantheus (LNTH) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations

February 26, 2026

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 4% year on year to $406.8 million. On the other hand, the company’s...

Via StockStory

Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

February 26, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Earnings: What To Look For From LNTH

February 24, 2026

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings this Thursday before the bell. Here’s what to expect.

Via StockStory

Topics Economy World Trade

Lantheus to Present at March 2026 Investor Conferences

February 24, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

2 Value Stocks to Target This Week and 1 Facing Headwinds

February 17, 2026

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

February 12, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

2 Small-Cap Stocks Worth Investigating and 1 We Avoid

February 03, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

January 31, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

3 Market-Beating Stocks for Long-Term Investors

January 11, 2026

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...

Via StockStory

Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies

January 02, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky

December 31, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the...

Via StockStory

Topics Stocks

Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year ↗

December 23, 2025

The move suggests that shrinking margins, leadership turnover, and a shifting product mix are quietly reshaping the Lantheus investment case.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

This Healthcare Stock Still Commands a Top 3 Portfolio Slot Despite a Steep Slide This Past Year ↗

December 23, 2025

After a bruising year for the stock, one fund leaned further into a business throwing off real cash and quietly reshaping its growth engine.

Via The Motley Fool

Topics Regulatory Compliance

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.